EXCAVATE-HT: A Bioinformatic Pipeline to Identify Targetable Genomic Variants for Allele-Specific Editing
Akshita G Saxena1,2, Grace D Ramey2,3, John A Capra3,4
1Gladstone Institute of Data Science and Biotechnology, San Francisco, CA 94158, USA.
Biorxiv : the Preprint Server for Biology
|August 1, 2026
Summary
EXCAVATE-HT is a new bioinformatics tool that identifies common genetic variants for allele-specific CRISPR/Cas editing. This approach can potentially treat over 30 times more patients for genetic diseases than current methods.
Area of Science:
- Genetics
- Bioinformatics
- Molecular Biology
Background:
- Allele-specific CRISPR/Cas editing offers a promising therapeutic strategy for genetic diseases.
- Targeting common single nucleotide polymorphisms (SNPs) can broaden treatment applicability compared to rare mutations.
- Existing tools for variant identification and guide RNA generation have limitations.
Purpose of the Study:
- To introduce EXCAVATE-HT, a novel bioinformatics tool for designing CRISPR libraries targeting common variants for allele-specific editing.
- To enable high-throughput identification of targetable SNPs and generation of allele-specific guide RNAs (gRNAs).
Main Methods:
- EXCAVATE-HT mines population variant data to identify common SNPs within user-defined genomic loci.
- The tool generates annotated lists of allele-specific gRNAs and gRNA pairs for targeted editing or excision.
- Designed and characterized gRNA libraries for allele-specific targeting of the CRX gene.
Main Results:
- EXCAVATE-HT successfully identified multiple allele-specific gRNAs for targeting the CRX gene.
- The developed gRNA libraries demonstrated potential for allele-specific editing.
- Identified excisions could potentially treat over 30-fold more patients than targeting a single CRX disease mutation.
Conclusions:
- EXCAVATE-HT is an effective tool for designing CRISPR libraries for allele-specific editing.
- This approach significantly expands the potential patient population for genetic disease therapies.
- EXCAVATE-HT addresses limitations in current CRISPR tool development for common variant targeting.


